Bacteriophage Therapy Market Increase In Transactional And Analytical Needs Across Several Industries 2028

 

Market Size and Analysis

Worldwide, the prevalence of antibiotic resistance is rising, increasing the necessity for efficient substitutes. The CDC estimates that 33 000 persons in Europe are afflicted with antibiotic-resistant bacterial illnesses each year. There will likely be a significant increase in bacterial phage demand as antibiotic resistance is projected to spread globally. Bacteriophage therapy is also known as phage therapy. Viral agents are used to treat bacterial illnesses. The bacterial viruses known as bacteriophages. Phages are viruses that kill bacteria but are safe for plants, animals, and people. The natural enemies of bacteria are assumed to be bacteriophages. Sewage, water, soil, and other places where bacteria are present are home to bacteriophages.

The global bacteriophage therapy market is estimated to be valued at US$ 1,148.6 million in 2020 and is expected to exhibit a CAGR of 3.7% over the forecast period (2020-2030).

Important Factors Driving the Global Bacteriophages Therapy Market

• Food deterioration contributes to a rise in the occurrence of foodborne illnesses. Viral and bacterial pathogens can be found in spoiled food. According to the WHO, over 600 million individuals (almost 1 in 10 people worldwide) will become unwell in 2019 after eating contaminated food, and 420,000 will die as a result. This will result in the loss of 33 million years of healthy life (DALYs). Additionally, 125,000 deaths annually from foodborne diseases are caused by children under the age of five. This element is accelerating the market for bacteriophages therapy.
• Bacteriophages attack microorganisms with extreme specificity. Its application is focused on a specific bacterial species, which considerably reduces any unintended effects on the microbiome or humans.